Treace Medical Concepts, Inc. (TMCI) Tops Q3 EPS by 2c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q3 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28). Revenue for the quarter came in at $50.2 million versus the consensus estimate of $49.66 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Envoy Medical (COCH) PT Lowered to $2 at H.C. Wainwright
• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance